References
- Giorgi-Renault, S., Renault, J., Gebel-Servolles, P., Baron, M., Paoletti, C., Cros, S., Bissery, M. C., Lavelle, F., and Atassi, G., Heterocyclic quinones 17. A new in vivo active antineoplastic drug. J. Med, Chem., 34, 38-46 (1991) https://doi.org/10.1021/jm00105a007
- Jeschke, P., Linder, W., Mueller, N., and Dehne, H. W., Fungicides based on amino-substituted quinohnequinones. Ger. Offen., DE 4,208,874 (1993); Chem. Abstr., 118, 233893 (1993)
- Mcginnis, M. R. and Rindali, M. G., Antifungal drug: In Lorian, V. (Eds.). Antibiotics in Laboratory Medicine (4th ed.). Williams and Wilkins, Baltimore, pp 176-211 (1996)
- Melesani, G., Marcolin, F., and Rodighiero, G., Synthesis of 5,8quinazolinedione. J. Med. Chem., 13, 161-162 (1970) https://doi.org/10.1021/jm00295a054
- Middleton, R. W. and Parrick, J., Heterocyclic quinones: Patai, S., Rappoport, Z.(Eds), The Chemistry of The Quinonoid Compounds. John Wiley & Sons: London, vol 2, pp 1019-1066 (1988)
- Park, H. J., Kim, Y.-S., Kim, J. S., Lee, H.-J., Lee, E.-J., Hwang, H. J., Suh, M.-E., Ryu, C.-K., and Lee, S. K., 6-Arylamino-7-chloro-quinazoline-5,8-diones as novel cytotoxic and DNA toposiomerase inhibitory agents. Bioorg. Med. Chem. Lett., 14, 3385-3388 (2004) https://doi.org/10.1016/j.bmcl.2004.04.094
- Renault, J., Giorgi-Renault, S., Baron, M., Mailliet, P., Paoletti, C., Cros, S., Viosin, E., and Renault, J., Heterocyclic quinone 4. A new highly cytotoxic drug: 6,7-bis(1-aziridinyl)-5,8quinazolinedione. J. Med. Chem., 26, 1715-1719 (1983) https://doi.org/10.1021/jm00366a011
- Roberts, H., Choo, W. M., Smith, S. C., Marzuki, S., Linnane, A. W, Porter, I. H., and Folkers, K., The site of inhibition of mitochondrial electron transfer by coenzyme Q analogs. Arch. Biochem. Biophys., 191, 306-315 (1978) https://doi.org/10.1016/0003-9861(78)90093-0
- Ryu, C.-K. and Kim, H. J., The synthesis of 6-(N-arylamino)-7-chloro-5,8-quinolinedione derivatives for evaluation of antifungal activities. Arch. Pharm. Res., 17, 139-144 (1994) https://doi.org/10.1007/BF02974248
- Ryu, C.-K., Shin, K.H., Seo, J. H., and Kim, H. J., 6-Arylamino5,8- quinazolinediones as potent inhibitors of endotheliumdependent vasorelaxation. European J. Med. Chem., 37, 77-82 (2002a) https://doi.org/10.1016/S0223-5234(01)01290-9
- Ryu, C.-K., Sun, Y. J., Shim, J.Y., You, H. J., Choi, K.U., and Lee, H., Synthesis and antifungal activities of 6,7-bis-[S(aryl)thio]-5,8-quinolinediones. Arch. Pharm. Res., 25, 784-789 (2002b).
- Ryu, C.-K., Yi, Y.-J., Choi, I. H., Chae, M. J., Han, J.-Y, Jung, O.J., and Lee, C.-O., Synthesis and cytotoxic activity of 6(substituted-phenyl)amino-5,8-quinazolinediones. Med. Chem. Res., 13 in press (2004)
- Shaikh, I. A., Johnson, F., and Grollman, A P., Structure-activity relationship among simple bicyclic analogues. Rate dependent of DNA degradation on quinone reduction potential. J. Med. Chem., 29, 1329-1340 (1986) https://doi.org/10.1021/jm00158a002
- Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, T. W., Bokesch, H., Kenney, S., and Boyd, M. R., New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst., 82,1107-1112 (1990) https://doi.org/10.1093/jnci/82.13.1107